Feldman, Darren R.

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine

Cancer Genomics and DiagnosticsBRCA gene mutations in cancer

Cited by 3,380

Progression‐free and overall survival in patients with relapsed/refractory germ cell tumors treated with single‐agent chemotherapy: Endpoints for clinical trial design

Feldman, D. R., Patil, S., Trinos, M. J., Carousso, M., Ginsberg, M. S., Sheinfeld, J., Bajorin, D. F., Bosl, G. J., & Motzer, R. J. (2012) · Cancer

Testicular diseases and treatmentsStatistical Methods in Clinical Trials

Cited by 68

Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases

Albany, C., Einhorn, L., Garbo, L., Boyd, T., Josephson, N., & Feldman, D. R. (2018) · The Oncologist

Testicular diseases and treatmentsLymphoma Diagnosis and Treatment

Cited by 51

Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study

Hoyt, M. A., Wang, A. W.-T., Ceja, R. C., Cheavens, J. S., Daneshvar, M. A., Feldman, D. R., Funt, S. A., & Nelson, C. J. (2023) · Annals of Behavioral Medicine

Cancer survivorship and careChildhood Cancer Survivors' Quality of Life

Cited by 17

Phase II Trial of Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Ashkar, R., Feldman, D. R., Adra, N., Zaid, M. A., Funt, S. A., Althouse, S. K., Perkins, S. M., Snow, C. I., Lazzara, K. M., Sego, L. M., et al. (2021) · Investigational New Drugs

Testicular diseases and treatmentsLymphoma Diagnosis and Treatment

Cited by 16